The clients at Arizona’s only government-run needle exchange one recent Friday included a middle-aged man driving a minivan, a man in his 30s who came by bicycle on his way to work, and a 19-year-old ...
Aviceda Therapeutics has got biotech financing in 2025 off to a flying start by raising $207.5 million to take its lead drug for sight-robbing disease geographic atrophy (GA) into pivotal testing. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results